Suraksha Diagnostic Secures SEBI Approval for IPO

ICICI Securities, Nuvama Wealth Management, and SBI Capital Markets are the book-running lead managers for the IPO, while Kfin Technologies will act as the registrar.

Suraksha Diagnostic, a diagnostic chain headquartered in Eastern India, has received approval from the Securities and Exchange Board of India (SEBI) for its initial public offering (IPO).

Reportedly, SEBI issued its observation letter on September 30, clearing the path for the company’s public listing.

The IPO will consist of an offer for sale of up to 19.19 million shares, each with a face value of INR 2.

Promoters Dr Somnath Chatterjee, Ritu Mittal, and Satish Kumar Verma will each sell up to 2.13 million shares.

Additionally, OrbiMed Asia II Mauritius plans to sell 10.66 million shares. Individual shareholders Munna Lal Kejriwal and Santosh Kumar Kejriwal will sell 799,556 and 1.33 million shares, respectively.

Suraksha Diagnostic has also received preliminary approvals from the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) for its listing.

Moreover, ICICI Securities, Nuvama Wealth Management, and SBI Capital Markets are the book-running lead managers for the IPO, while Kfin Technologies will act as the registrar.

Suraksha Diagnostics was established in 1992 as Suraksha Diagnostics & Eye Centre in Kolkata. It was among the pioneering diagnostic centers in the city, providing comprehensive pathology and radiology services under one roof.

Since its inception, Suraksha Diagnostics has operated as a full-service diagnostic center in Kolkata, offering a wide range of radiology and pathology services. For the fiscal year 2023-24, the company reported a consolidated net profit of ₹236.26 million and revenue of ₹2.19 billion.

The founders of Suraksha Diagnostics are Ritu Mittal and Somnath Chatterjee, with Ritu Mittal currently serving as the CEO.

The primary objective of Suraksha Diagnostics is to establish a robust network of laboratory, imaging, and delivery infrastructure that consistently elevates industry standards. The company specializes in various diagnostic tests, including those related to imaging, cardiology, neurology, gastroenterology, and radiology.

Stay tuned for more such updates on Digital Health News.